DGX vs OLMA · P/E 22, rev $5.94B vs $824.6M cap
Quest Diagnostics Incorporated (DGX) versus Olema Pharmaceuticals Inc (OLMA) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Olema Pharmaceuticals Inc (OLMA) is a biotechnology company listed on NASDAQ.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
OLMA does not have a complete income-statement cache yet.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. OLMA currently screens at market cap $824.6M.
Not investment advice. Open the DGX and OLMA stock pages for the full models.
Not investment advice.